The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Management of Cancer Cachexia: ASCO Guideline
Open accessAbstract
PURPOSE: To provide evidence-based guidance on the clinical management of cancer cachexia in adult patients with advanced cancer. METHODS: A systematic review of the literature collected evidence regarding nutritional, pharmacologic, and other interventions, such as exercise, for cancer cachexia. PubMed and the Cochrane Library were searched for randomized controlled trials (RCTs) and systematic reviews of RCTs published from 1966 through October 17, 2019. ASCO convened an Expert Panel to review the evidence and formulate recommendations. RESULTS: The review included 20 systematic reviews and 13 additional RCTs. Dietary counseling, with or without oral nutritional supplements, was reported to increase body weight in some trials, but evidence remains limited. Pharmacologic interventions associated with improvements in appetite and/or body weight include progesterone analogs and corticosteroids. The other evaluated interventions either had no benefit or insufficient evidence of benefit to draw conclusions on efficacy. Limitations of the evidence include high drop-out rates, consistent with advanced cancer, as well as variability across studies in outcomes of interest and methods for outcome assessment. RECOMMENDATIONS: Dietary counseling may be offered with the goals of providing patients and caregivers with advice for the management of cachexia. Enteral feeding tubes and parenteral nutrition should not be used routinely. In the absence of more robust evidence, no specific pharmacological intervention can be recommended as the standard of care; therefore, clinicians may choose not to prescribe medications specifically for the treatment of cancer cachexia. Nonetheless, when it is decided to trial a drug to improve appetite and/or improve weight gain, currently available pharmacologic interventions that may be used include progesterone analogs and short-term (weeks) corticosteroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767
Self-citationPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Self-citationESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
Self-citationBasch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0830 · Cited by 2,593
Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Self-citationAntipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017) · JAMA · doi:10.1001/jama.2017.7156 · Cited by 2,302
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1474 · Cited by 2,117
Self-citationBaracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.105 · Cited by 1,738
Self-citationShen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692
Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-30 · Cited by 1,268
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Fearon, K. C. H., Glass, D. J., & Guttridge, D. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.011 · Cited by 1,205
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K., Mackey, J. R., Koski, S., Pituskin, E., & Sawyer, M. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2242 · Cited by 1,104
Self-citationSchnipper, L. E., Davidson, N. E., Wollins, D. S., Tyne, C., Blayney, D. W., Blum, D., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6706 · Cited by 912
Self-citationDiagnostic Criteria for the Classification of Cancer-Associated Weight Loss
Martin, L., Senesse, P., Gioulbasanis, I., Antoun, S., Bozzetti, F., Deans, C., Strasser, F., Thoresen, L., Jagoe, R. T., Chasen, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.1894 · Cited by 798
Self-citationSchnipper, L. E., Davidson, N. E., Wollins, D. S., Blayney, D. W., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., Lyman, G. H., Meropol, N. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.2518 · Cited by 655
Self-citationSarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
Tan, B. H. L., Birdsell, L. A., Martin, L., Baracos, V. E., & Fearon, K. C. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1525 · Cited by 653
Self-citationTemel, J. S., Abernethy, A. P., Currow, D. C., Friend, J., Duus, E. M., Yan, Y., & Fearon, K. C. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00558-6 · Cited by 639
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
Meropol, N. J., Schrag, D., Smith, T. J., Mulvey, T. M., Langdon, R. M., Blum, D., Ubel, P. A., & Schnipper, L. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1183 · Cited by 638
Self-citationBody Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Mourtzakis, M., Mulder, K. E., Reiman, T., Butts, C. A., Scarfe, A. G., & Sawyer, M. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3067 · Cited by 619
Self-citationPatient-clinician communication: American Society of Clinical Oncology consensus guideline
Gilligan, T., Coyle, N., Frankel, R. M., Berry, D. L., Bohlke, K., Epstein, R. M., Finlay, E., Jackson, V. A., Lathan, C. S., Loprinzi, C. L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.2311 · Cited by 610
Self-citationCaan, B. J., Cespedes Feliciano, E. M., Prado, C. M., Alexeeff, S., Kroenke, C. H., Bradshaw, P., Quesenberry, C. P., Weltzien, E. K., Castillo, A. L., Olobatuyi, T. A., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0137 · Cited by 565
Jatoi, A., Windschitl, H. E., Loprinzi, C. L., Sloan, J. A., Dakhil, S. R., Mailliard, J. A., Pundaleeka, S., Kardinal, C. G., Fitch, T. R., Krook, J. E., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.567 · Cited by 543
Self-citationCost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Dusetzina, S. B., Winn, A. N., Abel, G. A., Huskamp, H. A., & Keating, N. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.9123 · Cited by 500
Moses, A. W. G., Slater, C., Preston, T., Barber, M. D., & Fearon, K. C. H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601620 · Cited by 452
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study
Muscaritoli, M., the PreMiO Study Group, Lucia, S., Farcomeni, A., Lorusso, V., Saracino, V., Barone, C., Plastino, F., Gori, S., Magarotto, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20168 · Cited by 438
Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer
Bachmann, J., Heiligensetzer, M., Krakowski-Roosen, H., Büchler, M. W., Friess, H., & Martignoni, M. E. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0505-z · Cited by 428
Strasser, F., Luftner, D., Possinger, K., Ernst, G., Ruhstaller, T., Meissner, W., Ko, Y.-D., Schnelle, M., Reif, M., & Cerny, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1847 · Cited by 413
Baldwin, C., Spiro, A., Ahern, R., & Emery, P. W. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr556 · Cited by 400
Dobs, A. S., Boccia, R. V., Croot, C. C., Gabrail, N. Y., Dalton, J. T., Hancock, M. L., Johnston, M. A., & Steiner, M. S. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70055-x · Cited by 391
Blauwhoff-Buskermolen, S., Versteeg, K. S., de van der Schueren, M. A. E., den Braver, N. R., Berkhof, J., Langius, J. A. E., & Verheul, H. M. W. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.6043 · Cited by 378
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., Krook, J. E., Wilwerding, M. B., Rowland, K. M., Camoriano, J. K., Novotny, P. J., & Christensen, B. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3299 · Cited by 343
Self-citationThalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
Gordon, J. N., Trebble, T. M., Ellis, R. D., Duncan, H. D., Johns, T., & Goggin, P. M. (2005) · Gut · doi:10.1136/gut.2004.047563 · Cited by 322
Solheim, T. S., Laird, B. J. A., Balstad, T. R., Stene, G. B., Bye, A., Johns, N., Pettersen, C. H., Fallon, M., Fayers, P., Fearon, K., et al. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12201 · Cited by 311
Self-citationInter-tissue communication in cancer cachexia
Argilés, J. M., Stemmler, B., López-Soriano, F. J., & Busquets, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0123-0 · Cited by 305
de van der Schueren, M. A. E., Laviano, A., Blanchard, H., Jourdan, M., Arends, J., & Baracos, V. E. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy114 · Cited by 300
Self-citationCancer cachexia—pathophysiology and management
Suzuki, H., Asakawa, A., Amitani, H., Nakamura, N., & Inui, A. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0787-0 · Cited by 268
Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer
Nipp, R. D., Fuchs, G., El-Jawahri, A., Mario, J., Troschel, F. M., Greer, J. A., Gallagher, E. R., Jackson, V. A., Kambadakone, A., Hong, T. S., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0255 · Cited by 265
Corticosteroid therapy of preterminal gastrointestinal cancer
Moertel, C. G., Schutt, A. J., Reitemeier, R. J., & Hahn, R. G. (1974) · Cancer · doi:10.1002/1097-0142(197406)33:6<1607::aid-cncr2820330620>3.0.co;2-v · Cited by 258
Blum, D., Stene, G. B., Solheim, T. S., Fayers, P., Hjermstad, M. J., Baracos, V. E., Fearon, K., Strasser, F., Kaasa, S., Block Lieve, V. D., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu086 · Cited by 255
Self-citationPatient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions
Streeter, S. B., Schwartzberg, L., Husain, N., & Johnsrud, M. (2011) · Journal of Oncology Practice · doi:10.1200/jop.2011.000316 · Cited by 248
Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer
Barret, M., Antoun, S., Dalban, C., Malka, D., Mansourbakht, T., Zaanan, A., Latko, E., & Taieb, J. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2014.894103 · Cited by 243
Systematic Review of the Treatment of Cancer-Associated Anorexia and Weight Loss
Yavuzsen, T., Davis, M. P., Walsh, D., LeGrand, S., & Lagman, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.8010 · Cited by 240
Katakami, N., Uchino, J., Yokoyama, T., Naito, T., Kondo, M., Yamada, K., Kitajima, H., Yoshimori, K., Sato, K., Saito, H., et al. (2018) · Cancer · doi:10.1002/cncr.31128 · Cited by 239
Lundholm, K., Daneryd, P., Bosaeus, I., Körner, U., & Lindholm, E. (2004) · Cancer · doi:10.1002/cncr.20160 · Cited by 235
Body-composition changes in patients who gain weight while receiving megestrol acetate.
Loprinzi, C. L., Schaid, D. J., Dose, A. M., Burnham, N. L., & Jensen, M. D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.152 · Cited by 230
Self-citation(2008) · Cited by 225
Yip, C., Goh, V., Davies, A., Gossage, J., Mitchell-Hay, R., Hynes, O., Maisey, N., Ross, P., Gaya, A., Landau, D. B., et al. (2014) · European Radiology · doi:10.1007/s00330-014-3110-4 · Cited by 223
Cancer Cachexia: Beyond Weight Loss
Bruggeman, A. R., Kamal, A. H., LeBlanc, T. W., Ma, J. D., Baracos, V. E., & Roeland, E. J. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2016.016832 · Cited by 221
Self-citationRibaudo, J. M., Cella, D., Hahn, E. A., Lloyd, S. R., Tchekmedyian, N. S., Roenn, J. V., & Leslie, W. T. (2000) · Quality of Life Research · doi:10.1023/a:1016670403148 · Cited by 202
McQuestion, M., Fitch, M., & Howell, D. (2011) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2010.07.006 · Cited by 197
Joglekar, S., Nau, P. N., & Mezhir, J. J. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.24025 · Cited by 193
Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome
Pascual López, A., Roqué i Figuls, M., Urrútia Cuchi, G., Graciela Berenstein, E., Almenar Pasies, B., Balcells Alegre, M., & Herdman, M. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.09.007 · Cited by 184
Shiffman, R. N., Michel, G., Rosenfeld, R. M., & Davidson, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000172 · Cited by 184
Currow, D., Temel, J. S., Abernethy, A., Milanowski, J., Friend, J., & Fearon, K. C. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx192 · Cited by 179
Ali, R., Baracos, V. E., Sawyer, M. B., Bianchi, L., Roberts, S., Assenat, E., Mollevi, C., & Senesse, P. (2016) · Cancer Medicine · doi:10.1002/cam4.621 · Cited by 177
Self-citationFarhangfar, A., Makarewicz, M., Ghosh, S., Jha, N., Scrimger, R., Gramlich, L., & Baracos, V. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.06.009 · Cited by 169
Self-citationHickish, T., Andre, T., Wyrwicz, L., Saunders, M., Sarosiek, T., Kocsis, J., Nemecek, R., Rogowski, W., Lesniewski-Kmak, K., Petruzelka, L., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30006-2 · Cited by 164
Lee, H., Troschel, F. M., Tajmir, S., Fuchs, G., Mario, J., Fintelmann, F. J., & Do, S. (2017) · Journal of Digital Imaging · doi:10.1007/s10278-017-9988-z · Cited by 163
Defining and Classifying Cancer Cachexia: A Proposal by the SCRINIO Working Group
Bozzetti, F., & Mariani, L. (2009) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607108325076 · Cited by 161
Hypothalamic mechanisms in cachexia
Grossberg, A. J., Scarlett, J. M., & Marks, D. L. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.011 · Cited by 160
Agteresch, H. J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.4.321 · Cited by 154
Maltoni, M. C., Nanni, O., Scarpi, E., Rossi, D., Serra, P., & Amadori, D. (2001) · Annals of Oncology · doi:10.1023/a:1011156811739 · Cited by 147
Macciò, A., Madeddu, C., Gramignano, G., Mulas, C., Floris, C., Sanna, E., Cau, M. C., Panzone, F., & Mantovani, G. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.12.435 · Cited by 146
Mochamat, Cuhls, H., Marinova, M., Kaasa, S., Stieber, C., Conrad, R., Radbruch, L., & Mücke, M. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12127 · Cited by 143
Turcott, J. G., Núñez, M. D. R. G., Flores‐Estrada, D., Oñate-Ocaña, L. F., Zatarain-Barrón, Z. L., Barrón, F., & Arrieta, O. G. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4154-9 · Cited by 134
Advani, S., Advani, P. G., VonVille, H. M., & Jafri, S. H. R. (2018) · BMC Cancer · doi:10.1186/s12885-018-5080-4 · Cited by 130
Strasser, F., Blum, D., von Moos, R., Cathomas, R. L., Ribi, K., Aebi, S. P., Betticher, D. C., Hayoz, S., Klingbiel, D., Brauchli, P., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv576 · Cited by 127
Ries, A., Trottenberg, P., Elsner, F., Stiel, S., Haugen, D. F., Kaasa, S., & Radbruch, L. (2011) · Palliative Medicine · doi:10.1177/0269216311418709 · Cited by 126
Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review
Solheim, T. S., Fearon, K. C. H., Blum, D., & Kaasa, S. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.724536 · Cited by 122
Clinical Outcomes and Contributors to Weight Loss in a Cancer Cachexia Clinic
Fabbro, E. D., Hui, D. S. C., Dalal, S., Dev, R., Nooruddin, Z. I., & Bruera, E. D. (2011) · Journal of Palliative Medicine · doi:10.1089/jpm.2011.0098 · Cited by 121
Self-citationPhase II Trial of Mirtazapine for Cancer-Related Cachexia and Anorexia
Riechelmann, R. P., Burman, D., Tannock, I. F., Rodin, G., & Zimmermann, C. (2009) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909109345685 · Cited by 121
Dabiri, S., Popuri, K., Feliciano, E. M. C., Caan, B. J., Baracos, V. E., & Beg, M. F. (2019) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2019.04.007 · Cited by 117
Self-citationHuhmann, M. B., & August, D. A. (2008) · Nutrition in Clinical Practice · doi:10.1177/0884533608314530 · Cited by 108
Balstad, T. R., Solheim, T. S., Strasser, F., Kaasa, S., & Bye, A. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.02.005 · Cited by 104
Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial.
Navari, R. M., & Brenner, M. C. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-009-0739-7 · Cited by 99
Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer
Chlebowski, R. T., Herrold, J. N., Ali, I., Oktay, E., Chlebowski, J. S., Ponce, A. T., Heber, D., & Block, J. B. (1986) · Cancer · doi:10.1002/1097-0142(19860701)58:1<183::aid-cncr2820580131>3.0.co;2-3 · Cited by 97
Utech, A. E., Tadros, E. M., Hayes, T. G., & Garcia, J. M. (2012) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-012-0075-5 · Cited by 97
Amano, K., Baracos, V. E., & Hopkinson, J. B. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.08.006 · Cited by 97
Self-citationPoole, K., & Froggatt, K. A. (2002) · Palliative Medicine · doi:10.1191/0269216302pm593oa · Cited by 96
Heidelberger, V., Goldwasser, F., Kramkimel, N., Jouinot, A., Huillard, O., Boudou, P., Chanal, J., Arrondeau, J., Franck, N., Alexandre, J., et al. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0464-x · Cited by 96
Obling, S. R., Wilson, B., Pfeiffer, P., & Kjeldsen, J. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.12.011 · Cited by 85
Werner, K., de Gaudry, D. K., Taylor, L. A., Keck, T., Unger, C., Hopt, U. T., & Massing, U. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0495-5 · Cited by 83
A randomized trial of adjunct testosterone for cancer‐related muscle loss in men and women
Wright, T., Dillon, E. L., Durham, W., Chamberlain, A., Randolph, K. M., Danesi, C., Horstman, A., Gilkison, C., Willis, M., Richardson, G., et al. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12295 · Cited by 80
Nutritional support at the end of life
Orrevall, Y. (2014) · Nutrition · doi:10.1016/j.nut.2014.12.004 · Cited by 77
Yennurajalingam, S., Willey, J. S., Palmer, J. L., Allo, J. A., Fabbro, E. D., Cohen, E. N., Tin, S., Reuben, J. M., & Bruera, E. D. (2012) · Journal of Palliative Medicine · doi:10.1089/jpm.2012.0146 · Cited by 74
Self-citationStephens, N. A., Skipworth, R. J. E., Gallagher, I. J., Greig, C. A., Guttridge, D. C., Ross, J. A., & Fearon, K. C. H. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12005 · Cited by 73
Nutrition therapy in cachectic cancer patients. The Tight Caloric Control (TiCaCo) pilot trial
Waele, E. D., Mattens, S., Honoré, P. M., Spapen, H. D., Grève, J. D., & Pen, J. J. (2015) · Appetite · doi:10.1016/j.appet.2015.04.049 · Cited by 67
Agteresch, H. J., Rietveld, T., Kerkhofs, L. G. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.2.371 · Cited by 60
Defining the role of dietary intake in determining weight change in patients with cancer cachexia
Nasrah, R., Kanbalian, M., Borch, C. V. D., Swinton, N., Wing, S. S., & Jagoe, R. T. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.12.012 · Cited by 59
Heidelberger, V., Goldwasser, F., Kramkimel, N., Jouinot, A., Huillard, O., Boudou, P., Chanal, J., Arrondeau, J., Franck, N., Alexandre, J., et al. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0475-7 · Cited by 59
Agteresch, H. J., Burgers, S. A., van der Gaast, A., Wilson, J. H. P., & Dagnelie, P. C. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200309000-00009 · Cited by 55
Kapoor, N., Naufahu, J., TEWFİK, S., Bhatnagar, S., Garg, R. K., & Tewfik, I. (2016) · Integrative Cancer Therapies · doi:10.1177/1534735416651968 · Cited by 53
Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis
Bai, Y., Hu, Y., Zhao, Y., Yu, X., Xu, J., Hua, Z., & Zhao, Z. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-016-3560-0 · Cited by 52
Nishie, K., Yamamoto, S., Nagata, C., Koizumi, T., & Hanaoka, M. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.07.023 · Cited by 52
Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue
Strasser, F. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283025e27 · Cited by 51
Ma, Y., Yu, J., Xiao, J., & Cao, B. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2015.976315 · Cited by 50
Tobberup, R., Thoresen, L., Falkmer, S., Yilmaz, M., Solheim, T. S., & Balstad, T. R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.04.014 · Cited by 50
Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: A systematic review
Reid, J., Hughes, C., Murray, L., Parsons, C., & Cantwell, M. M. (2012) · Palliative Medicine · doi:10.1177/0269216312441382 · Cited by 49
Sasaki, S., Oki, E., Saeki, H., Shimose, T., Sakamoto, S., Hu, Q., Kudo, K., Tsuda, Y., Nakashima, Y., Ando, K., et al. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01460-8 · Cited by 48
Pezaro, C. J., Mukherji, D., Tunariu, N., Cassidy, A. M., Omlin, A. G., Bianchini, D., Seed, G., Reid, A. H. M., Olmos, D., Bono, J. S. D., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.340 · Cited by 47
Body composition and survival in the early clinical trials setting
Rodrigues, H. V., Baracos, V. E., Wheler, J. J., Parsons, H. A., Hong, D. S., Naing, A., Fu, S., Falchoock, G., Tsimberidou, A. M., Piha-Paul, S. A., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.026 · Cited by 43
Self-citationJatoi, A., Steen, P. D., Atherton, P. J., Moore, D. F., Rowland, K. M., Le-Lindqwister, N. A., Adonizio, C. S., Jaslowski, A. J., Sloan, J. A., & Loprinzi, C. L. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx232 · Cited by 42
Self-citationBeijer, S., Hupperets, P. S. G. J., van den Borne, B. E., Eussen, S. R. B. M., van Henten, A. M. J., Everdingen, M. H. J. V. D. B.-V., de Graeff, A., Ambergen, T., van den Brandt, P. A., & Dagnelie, P. C. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32832d4f22 · Cited by 41
Kouchaki, B., Janbabai, G., Alipour, A., Ala, S., Borhani, S., & Salehifar, E. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4047-y · Cited by 40
Oh, S. Y., Jun, H. J., Park, S. J., Park, I. K., Lim, G. J., Yu, Y., Cho, S.-J., & Song, A. (2014) · Journal of Palliative Medicine · doi:10.1089/jpm.2014.0082 · Cited by 37
Beijer, S., Hupperets, P. S. G. J., van den Borne, B. E. E. M., Wijckmans, N. E. G., Spreeuwenberg, C., van den Brandt, P. A., & Dagnelie, P. C. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.01.023 · Cited by 32
How much does reduced food intake contribute to cancer-associated weight loss?
Martin, L., & Kubrak, C. (2018) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000379 · Cited by 29
Novel investigational biologics for the treatment of cancer cachexia
JOSEPH, D. R., Heavey, S. F., Revta, C., & Roeland, E. J. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.907788 · Cited by 23
Self-citationUse of Dietary Supplements at a Comprehensive Cancer Center
Luo, Q., & Asher, G. N. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0183 · Cited by 23
Cited by
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆
Arends, J., Strasser, F., Gonella, S., Solheim, T. S., Madeddu, C., Ravasco, P., Buonaccorso, L., de van der Schueren, M. A. E., Baldwin, C., Chasen, M., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100092 · Cited by 586
Ponsegromab for the Treatment of Cancer Cachexia
Groarke, J. D., Crawford, J., Collins, S. M., Lubaczewski, S., Roeland, E. J., Naito, T., Hendifar, A. E., Fallon, M., Takayama, K., Asmis, T., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2409515 · Cited by 319
Self-citationCancer Cachexia: Definition, Staging, and Emerging Treatments
Ni, J., & Zhang, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s261585 · Cited by 290
Bargetzi, L., Brack, C., Herrmann, J., Bargetzi, A., Hersberger, L., Bargetzi, M., Kaegi-Braun, N., Tribolet, P., Gomes, F., Hoess, C., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.05.793 · Cited by 186
Sandhya, L., Devi Sreenivasan, N., Goenka, L., Dubashi, B., Kayal, S., Solaiappan, M., Govindarajalou, R., KT, H., & Ganesan, P. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.01997 · Cited by 115
Metadata
- Authors
- Roeland, E. J., Bohlke, K., Baracos, V. E., Bruera, E., del Fabbro, E., Dixon, S., Fallon, M., Herrstedt, J., Lau, H., Platek, M., Rugo, H. S., Schnipper, H. H., Smith, T. J., Tan, W., & Loprinzi, C. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2020-07-20
- Volume
- 38
- Issue
- 21
- Pages
- 2438-2453
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W3028453792
- Cited by
- 644
- References
- 110
- FWCI
- 37.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.